BANSARI PATEL: Open Payments
NPI 1568970291 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 24 payments from 9 companies in 2025. Trend: 2023 $284 · 2024 $396 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $255 |
| ABBVIE INC. | 5 | $108 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| Novo Nordisk Inc | 2 | $45 |
| SCPHARMACEUTICALS INC. | 1 | $41 |
| PFIZER INC. | 2 | $32 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: JARDIANCE, DALVANCE, ZERBAXA, Ozempic, UBRELVY, FUROSCIX, ELIQUIS, Assure WCD.
Industry payments across NC — which companies pay providers there.
